Hedgepath, Llc - Net Worth and Insider Trading
Hedgepath, Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Hedgepath, Llc owns 1 companies in total, including Inhibitor Therapeutics Inc (INTI) .
Click here to see the complete history of Hedgepath, Llc’s form 4 insider trades.
Insider Ownership Summary of Hedgepath, Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| INTI | Inhibitor Therapeutics Inc | 2014-08-14 | 10 percent owner |
Hedgepath, Llc Trading Performance
Hedgepath, Llc Ownership Network
Hedgepath, Llc Owned Company Details
What does Inhibitor Therapeutics Inc do?
Who are the key executives at Inhibitor Therapeutics Inc?
Hedgepath, Llc is the 10 percent owner of Inhibitor Therapeutics Inc. Other key executives at Inhibitor Therapeutics Inc include 10 percent owner Ronald E Osman Irrevocable Trust Iii , director & 10 percent owner Ronald E Osman , and 10 percent owner Tpb 2012 Llc .
Inhibitor Therapeutics Inc (INTI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Inhibitor Therapeutics Inc (INTI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Inhibitor Therapeutics Inc (INTI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Inhibitor Therapeutics Inc (INTI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Inhibitor Therapeutics Inc Insider Transactions
Hedgepath, Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Hedgepath, Llc. You might contact Hedgepath, Llc via mailing address: 324 South Hyde Park Ave, Suite 350, Tampa Fl 33606.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
